FDA Cites Rhode Island Drugmaker for Multiple Violations

Drug Industry Daily
A A
Quality violations at Tedor Pharma’s Cumberland, Rhode Island site netted the drugmaker a Form 483 from the FDA for inadequate testing, cleaning and calibration procedures.

To View This Article:

Login

Subscribe To Drug Industry Daily